Treatment of pulmonary hypertension in infants, children and young adults. 2026 consensus statement from the European Pediatric Pulmonary Vascular Disease Network (EPPVDN), endorsed by AHA, AEPC, EACTS, ESPR, PASCAR, PCS, and PICS
Treatment of pulmonary hypertension in infants, children and young adults. 2026 consensus statement from the European Pediatric Pulmonary Vascular Disease Network (EPPVDN), endorsed by AHA, AEPC, EACTS, ESPR, PASCAR, PCS, and PICS. // The Journal of Heart and Lung Transplantation. – URL: https://www.sciencedirect.com/science/article/pii/S1053249826000173?dgcid=rss_sd_all
Treatment of pulmonary hypertension in infants, children and young adults. 2026 consensus statement from the European Pediatric Pulmonary Vascular Disease Network (EPPVDN), endorsed by AHA, AEPC, EACTS, ESPR, PASCAR, PCS, and PICS. The Journal of Heart and Lung Transplantation. https://www.sciencedirect.com/science/article/pii/S1053249826000173?dgcid=rss_sd_all
“Treatment of pulmonary hypertension in infants, children and young adults. 2026 consensus statement from the European Pediatric Pulmonary Vascular Disease Network (EPPVDN), endorsed by AHA, AEPC, EACTS, ESPR, PASCAR, PCS, and PICS.” The Journal of Heart and Lung Transplantation.
@article{article90912,
title = {Treatment of pulmonary hypertension in infants, children and young adults. 2026 consensus statement from the European Pediatric Pulmonary Vascular Disease Network (EPPVDN), endorsed by AHA, AEPC, EACTS, ESPR, PASCAR, PCS, and PICS},
journal = {The Journal of Heart and Lung Transplantation},
url = {https://www.sciencedirect.com/science/article/pii/S1053249826000173?dgcid=rss_sd_all}
}